TABLE 2

Summary of pharmacokinetic parameters of total radioactivity in human plasma after a single oral dose of 10 mg of [14C]peliglitazar

Data are presented as means ± S.D. All P > 0.05, t test, group 1 versus group 2.

GroupCmaxAUC(0–12 h)Tmaxt1/2
ng/mlng · h/mlhh
All subjects (n = 8)251 ± 47958 ± 3391.1 ± 0.43.5 ± 1.1
Group 1 (n = 6)257 ± 561035 ± 3281.1 ± 0.53.6 ± 1.1
Group 2 (n = 4)242 ± 35844 ± 3711.0 ± 0.43.3 ± 1.2